1.
Clin Infect Dis
; 2024 03 29.
Artículo
en Inglés
| MEDLINE
| ID: mdl-38552199
RESUMEN
Precision daptomycin dosing faces clinical implementation barriers despite known exposure-safety concerns with the use of twice the regulatory-approved doses. We propose achieving a single 7-11â hour post-dose plasma target concentration of 30â mg/L to 43â mg/L to be a practical starting point to facilitate precision daptomycin dosing.